Upbeat broker recommendations for Sino Biopharmaceutical

The Sino Biopharmaceutical (HKG:1177) share price has risen by 6.18% over the past month and it’s currently trading at 11.34. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Sino Biopharmaceutical currently has:

• 9 Buy recommendations
• 4 Hold recommendations
• 1 Sell recommendations

This suggests that analysts are generally positive about the outlook.

At its current price of 11.34, shares in Sino Biopharmaceutical are trading at a discount of -11.1% to its 52 week high price. The 1-year performance of the shares has been 50.4%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Sino Biopharmaceutical it's worth doing some investigation yourself.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Sino Biopharmaceutical it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Sino Biopharmaceutical that you can find out about here.